Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
RDHLRedHill Biopharma Ltd.
| Figure | RDHLRedHill Biopharma Ltd.FY2024 · Dec |
|---|---|
| Revenue | $8.04M |
| Revenue, yoy | +23.2% |
| Net income | $8.27M |
| Net income, yoy | −134.6% |
| Net margin | -102.8% |
| Free cash flow | $9.38M |
| FCF margin | -116.6% |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2020–FY2024 · USD
From SEC EDGARSame fiscal periods, as filed